Frontlight ResearchEarly access
Liver and biliary tract cancer trials in United States
302 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleFOG-001 in Locally Advanced or Metastatic Solid Tumors
- Where
- Aurora, Baltimore, Boston, Charlottesville, Cleveland, Durham, Houston, Jacksonville, Lake Mary, Los Angeles, Madison, Minneapolis, Nashville, New Haven, New York, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Antonio, San Francisco, Santa Monica, Scottsdale, St Louis, Tucson, Washington D.C.
- Age
- 18 years and over
- People
- 619 worldwide
- Run by
- Parabilis Medicines, Inc.
See details and how to joinNCT05919264 - Phase 2Taking peopleA Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
- Where
- Houston
- Age
- 18 years and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05967182 - No phaseTaking peopleImpact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
- Where
- Houston
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05143619 - No phaseNot yet taking people in United StatesYttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma
- Where
- San Francisco
- Age
- 22 years and over
- People
- 64
- Run by
- University of California, San Francisco
See details and how to joinNCT07110233 - Phase 1/2Taking peopleModified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 85
- Run by
- Mayo Clinic
See details and how to joinNCT03942328 - Phase 2Taking peopleA Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
- Where
- Birmingham, Buffalo, Columbus
- Age
- 18 years and over
- People
- 38
- Run by
- Mehmet Akce
See details and how to joinNCT06728410 - Phase 1Taking peopleA Study of PHST001 in Advanced Solid Tumors
- Where
- Ann Arbor, Beverly Hills, Boston, Chicago, Denver, Durham, Fairfax, Fort Worth, Grand Rapids, Houston, Irving, Lake Success, Los Angeles, Nashville, New Haven, New York, Palo Alto, San Antonio
- Age
- 18 years and over
- People
- 426
- Run by
- Pheast Therapeutics
See details and how to joinNCT06840886 - Phase 1Taking peopleA Study of ZW251 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Hackensack, Houston, Louisville, New York, San Antonio, San Francisco, Santa Monica
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Zymeworks BC Inc.
See details and how to joinNCT07164313 - Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Austin, Bedford, Boston, Charleston, Cleveland, Dallas, Denver, Detroit, Durham, Fairfax, Houston, Irvine, La Jolla, Los Angeles, Madison, Miami, Nashville, Newark, New Haven, New York, Oklahoma City, Orlando, Philadelphia, Pittsburgh, Port Charlotte, Portland, San Antonio, Seattle, York
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - Phase 2Taking peopleComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT06265285 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Austin, Baltimore, Boston, Celebration, Charlottesville, Chicago, Cleveland, Dallas, Detroit, Durham, East Brunswick, Gainesville, Hackensack, Hershey, Indianapolis, Irving, Jacksonville, Las Vegas, Littleton, Louisville, Miami, Milwaukee, Myrtle Beach, Nashville, Newark, New Haven, New York, Omaha, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Plano, Plantation, Portland, Rochester, Santa Barbara, Syracuse, Tampa, Tucson, Tyler
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 2Taking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Commack, Houston, Louisville, Orange, Palo Alto, Providence, Santa Rosa
- Age
- 18 years and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - Phase 2Taking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - Phase 3Taking peopleA Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- Where
- Buffalo, Cleveland, Columbus, Dallas, Detroit, Duarte, Las Vegas, Louisville, Minneapolis, New Brunswick, New Orleans, New York, Oklahoma City, Orange, Santa Monica, Seattle, Tampa, Zion
- Age
- 18 years and over
- People
- 480
- Run by
- J-Pharma Co., Ltd.
See details and how to joinNCT07265674 - Phase 1/2Taking peopleSpevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Where
- Boston, Denver, Duarte, Durham, Fairfax, Houston, Iowa City, Los Angeles, Louisville, Madison, Pittsburgh
- Age
- 18 years and over
- People
- 350
- Run by
- Phanes Therapeutics
See details and how to joinNCT05482893 - Phase 1/2Taking peopleStudy of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
- Where
- Baltimore, Birmingham, Charlottesville, Houston, Jacksonville, Lexington, New York, Omaha, Orange, Phoenix, Rochester, Seattle, St Louis
- Age
- 18 years and over
- People
- 590
- Run by
- RayzeBio, Inc.
See details and how to joinNCT06726161 - Phase 3Taking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Ann Arbor, Aurora, Baltimore, Birmingham, Chicago, Detroit, Duarte, Gainesville, Hartford, Houston, Indianapolis, Jacksonville, Lancaster, Los Angeles, Louisville, Marietta, Miami, Mineola, Nashville, New Haven, New York, Oklahoma City, Omaha, Orange, Palo Alto, Philadelphia, Phoenix, Pierre, Pittsburgh, Portland, Providence, Rochester, Santa Fe, Seattle, Sioux Falls, Tucson, Washington D.C.
- Age
- 18 years and over
- People
- 1,100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - Phase 4Taking peopleNational Liver Cancer Screening Trial
- Where
- Ann Arbor, Boston, Chapel Hill, Chicago, Cleveland, Dallas, Detroit, Houston, Indianapolis, Los Angeles, Manhasset, Minneapolis, Philadelphia, Redwood City, Richmond, Roseville, San Francisco
- Age
- 18 years to 85 years
- People
- 5,500
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06084234 - No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Age
- 18 years to 130 years
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - Phase 1/2Taking peopleClinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- Where
- Boston, Nashville
- Age
- 18 years and over
- People
- 147 worldwide
- Run by
- Yuhan Corporation
See details and how to joinNCT05523947 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Albuquerque, Boston, Cincinnati, Columbus, Commack, East Brunswick, Grand Rapids, Houston, Kansas City, Los Angeles, Madison, Muncie, Nashville, Portland, San Diego, Santa Rosa
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - Phase 1Taking peoplePemigatinib + Afatinib in Advanced Refractory Solid Tumors
- Where
- Boston
- Age
- 18 years and over
- People
- 32
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06302621 - Phase 2Not yet taking people in United StatesMultiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 46
- Run by
- University of Southern California
See details and how to joinNCT07836712 - Phase 1Taking peopleA Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
- Where
- Chicago, Duarte, Irvine, Los Angeles, Nashville, New York, Orange, Philadelphia, Santa Monica, St Louis
- Age
- 18 years and over
- People
- 232 worldwide
- Run by
- AbbVie
See details and how to joinNCT06858813 · EU 2024-518012-39-00 - No phaseTaking peopleProtoacoustic Imaging For 3D Mapping
- Where
- Oklahoma City
- Age
- 18 years and over
- People
- 24
- Run by
- University of Oklahoma
See details and how to joinNCT07832617